Can contrast-enhanced sonography distinguish benign from malignant breast masses?

Journal of Clinical Ultrasound

Volumn 38, Issue 4, 2010, Pages 177-181

  Sorelli, P G ^a   Cosgrove, D O ^a   Svensson, W E ^a   Zaman, N ^a   Satchithananda, K ^a   Barrett, N K ^b   Lim, A K P ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Breast lesions; Microbubbles; Ultrasound

Indexed keywords

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; BREAST TUMOR; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ECHOMAMMOGRAPHY; EVALUATION; FEMALE; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; MICROBUBBLE; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; MICROBUBBLES; MIDDLE AGED; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY, MAMMARY; YOUNG ADULT;

EID: 77951790587     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20671     Document Type: Article

References (14)

1. D'Arcy TJ, Jayaram V, Lynch M, et al. Ovarian cancer detected non-invasively by contrast-enhanced power Doppler ultrasound. BJOG 2004; 111:619.
2. Soo MS, Rosen EL, Baker JA, et al. Negative predictive value of sonography with mammography in patients with palpable breast lesions. AJR Am J Roentgenol 2001;177:1167.
3. Moy L, Slanetz PJ, Moore R, et al. Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review. Radiology 2002;225:176.
4. Shetty MK, Shah YP. Prospective evaluation of the value of negative sonographic and mammo-graphic findings in patients with palpable abnormalities of the breast. J Ultrasound Med 2002;21:1211.
5. Ricci P, Cantisani V, Ballesio L, et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med 2007;28:57.
6. Barnard S, Leen E, Cooke T, et al. A contrast-enhanced ultrasound study of benign and malignant breast tissue. S Afr Med J 2008;98:5:386.
7. Du J, Li FH, Fang H, et al. Microvascular architecture of breast lesions: evaluation with contrast-enhanced ultrasonographic micro flow imaging. J Ultrasound Med 2008;27:6:833.
8. Liu H, Jiang YX, Liu JB, et al. Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations. Breast 2008;17:5:532.
9. Stavros AT, Thickman D, Rapp CL, et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995;196:123.
10. Chao T-C, Lo Y-F, Chen S-C et al. Prospective sonographic study of 3093 breast tumours. J Ultrasound Med 1999;18:363.
11. Sahin-Akyar G, Sumer H. Color Doppler ultrasound and spectral analysis of tumor vessels in the differential diagnosis ofsolid breast masses. Invest Radiol 1996;31:72.
12. Phillips P, Gardner E. Contrast-agent detection and quantification. Eur Radiol 2004;14:P4.
13. Solbiati L, Tonolini M, Cova L, et al. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001;11:E15.
14. Goldberg BB, Merton DA, Liu JB, et al. Contrast-enhanced sonographic imaging of lymphatic channels and sentinel lymph nodes. J Ultrasound Med 2005;24:953.